MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 131-139

  Han, Zhiyuan ^a   Yang, Qiaoyuan ^a   Liu, Binbin ^a   Wu, Jianjun ^a   Li, Yuanqi ^a   Yang, Chengfeng ^b   Jiang, Yiguo ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 622; RESVERATROL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL VIABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84855380396     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr226     Document Type: Article

References (48)

1. Anand,P. et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res., 25, 2097-2116.
2. Li,D. et al. (2001) Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res., 61, 1445-1450.
3. Jiang,Y. et al. (2001) [Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene]. Wei Sheng Yan Jiu, 30, 129-131.
4. Zhou,L. et al. (2008) Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE. Toxicol. Sci., 105, 286-294.
5. Zhang,L. et al. (2008) TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology, 252, 49-55.
6. Liu,L. et al. (2010) Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Life Sci., 86, 192-198.
7. Liu,L. et al. (2010) miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicol In Vitro, 24, 1168-1175.
8. Jiang,Y. et al. (2011) miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Toxicol. Sci., 119, 50-60.
9. Lim,L.P. et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.
10. Bentwich,I. et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet., 37, 766-770.
11. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
12. Chen,C.Z. et al. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-86.
13. Hayashita,Y. et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res., 65, 9628-9632.
14. Chang,T.C. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
15. Cho,W.C. (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol., 42, 1273-1281.
16. Tazawa,H. et al. (2007) Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
17. Johnson,S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
18. Yang,Q. et al. (2011) Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis, 32, 713-722.
19. Kumar,M.S. et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl Acad. Sci. USA, 105, 3903-3908.
20. Cao,P. et al. (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol. Cancer, 9, 108.
21. Varambally,S. et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science, 322, 1695-1699.
22. Wang,Z. et al. (2011) Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol. Sci., 121, 110-122.
23. Huang,C. et al. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 20, 237-242.
24. Kaur,M. et al. (2009) Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J. Nutr., 139, 1806S-1812S.
25. Bishayee,A. (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. (Phila.), 2, 409-418.
26. Li,Y. et al. (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res., 27, 1027-1041.
27. Whyte,L. et al. (2007) Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res., 67, 12007-12017.
28. Athar,M. et al. (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 224, 274-283.
29. Tili,E. et al. (2010) Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFbeta signaling pathway in SW480 cells. Biochem. Pharmacol., 80, 2057-2065.
30. Tili,E. et al. (2010) Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis, 31, 1561-1566.
31. Campbell,P.M. et al. (2007) K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res., 67, 2098-2106.
32. Kim,M.J. et al. (2011) Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. J. Biol. Chem., 286, 12924-12932.
33. Voice,J.K. et al. (1999) Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem., 274, 17164-17170.
34. Aziz,M.H. et al. (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol., 23, 17-28.
35. Wang,X.Y. et al. (2010) Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol. Cell. Biochem., 345, 283-290.
36. Dahiya,N. et al. (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One, 3, e2436.
37. Barker,E.V. et al. (2009) microRNA evaluation of unknown primary lesions in the head and neck. Mol. Cancer, 8, 127.
38. Guo,X.B. et al. (2011) Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J. Gastroenterol., 17, 1895-1902.
39. Bae,S. et al. (2011) Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol. Cells, 32, 243-249.
40. Hollander,M.C. et al. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene, 30, 1812-1821.
41. Yoon,Y.K. et al. (2010) KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach. Mol. Carcinog., 49, 353-362.
42. Keohavong,P. et al. (2001) Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients. Br. J. Cancer, 85, 235-241.
43. Volm,M. et al. (2002) Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype. Anticancer Res., 22, 2321-2324.
44. Xie,X.Y. et al. (2010) Bronchogenic and alveologenic tumors in mice induced by N-nitrosopiperidine. Biochem. Cell Biol., 88, 775-782.
45. Tsang,W.P. et al. (2009) The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis, 30, 953-959.
46. Yu,S. et al. (2010) miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res., 70, 6015-6025.
47. Hatley,M.E. et al. (2010) Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer cell, 18, 282-293.
48. Adjei,A.A. (2008) K-ras as a target for lung cancer therapy. J. Thorac. Oncol., 3, S160-S163.